PLASMA HEPARIN CONCENTRATIONS DURING SUBCUTANEOUS HEPARIN THERAPY

被引：7

作者：

PITNEY, WR ^{[1
]}

DEAN, S ^{[1
]}

机构：

[1] UNIV NEW S WALES,ST GEORGE HOSP,SCH MED,MED PROFESSIONAL UNIT,KOGARAH 2217,NEW S WALES,AUSTRALIA

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1976年 / 6卷 / 05期

关键词：

D O I：

10.1111/j.1445-5994.1976.tb03034.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：454 / 458

页数：5

共 11 条

[1]

[Anonymous], 1975, LANCET, V2, P45

[2] MEASUREMENT OF HEPARIN IN PATIENTS RECEIVING SUBCUTANEOUS HEPARIN THERAPY [J].

DENSON, KWE ;

BONNAR, J .

BRITISH JOURNAL OF HAEMATOLOGY, 1975, 30 (02) :139-144

[3] MEASUREMENT OF HEPARIN - METHOD BASED ON POTENTIATION OF ANTIFACTOR XA [J].

DENSON, KWE ;

BONNAR, J .

THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1973, 30 (03) :471-479

[4]

KAKKAR V, 1974, THROMB DIATH, V33, P87

[5]

PERRY PJ, 1974, CLIN PHARMACOL THER, V16, P514

[6]

WESSLER S, 1968, J LAB CLIN MED, V72, P256

[7] PROPHYLACTIC ANTICOAGULANT THERAPY IN PREVENTION OF CALF-VEIN THROMBOSIS AFTER MYOCARDIAL-INFARCTION [J].

WRAY, R ;

MAURER, B ;

SHILLINGFORD, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (16) :815-817

[8] HEPARIN-ACCELERATED INHIBITION OF ACTIVATED FACTOR-X BY ITS NATURAL PLASMA INHIBITOR [J].

YIN, ET ;

WESSLER, S .

BIOCHIMICA ET BIOPHYSICA ACTA, 1970, 201 (02) :387-&

[9]

YIN ET, 1973, BLOOD, V42, P1002

[10]

YIN ET, 1973, J LAB CLIN MED, V81, P298

← 1 2 →